Creative Medical Technology Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Creative Medical Technology Holdings, Inc. (CELZ) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 1-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-07
- Creative Medical Technology Holdings, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- Creative Medical Technology Holdings, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- Creative Medical Technology Holdings, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
- Creative Medical Technology Holdings, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-03-31 was 0.00%.
- Creative Medical Technology Holdings, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- Creative Medical Technology Holdings, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- Creative Medical Technology Holdings, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- Creative Medical Technology Holdings, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-07 | |||||
| 2025-12-31 | 0.00% 10-K · filed 2026-03-20 | |||||
| 2025-10-29 | 0.00% 10-Q · filed 2026-08-07 | |||||
| 2025-06-30 | 0.00% 10-Q · filed 2025-08-08 | |||||
| 2025-03-31 | 0.00% 10-Q · filed 2025-05-09 | |||||
| 2025-03-06 | 0.00% 10-Q · filed 2026-08-07 | |||||
| 2024-12-31 | 0.00% 10-K · filed 2025-03-14 | |||||
| 2024-09-30 | 0.00% 10-Q · filed 2024-11-08 | |||||
| 2024-06-30 | 0.00% 10-Q · filed 2024-08-09 | |||||
| 2024-03-31 | 0.00% 10-Q · filed 2024-05-10 | |||||
| 2023-12-31 | 0.00% 10-K · filed 2024-03-22 | |||||
| 2023-09-30 | 0.00% 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | 0.00% 10-Q · filed 2023-08-11 | |||||
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-12 | |||||
| 2022-12-31 | 0.00% 10-K · filed 2023-03-31 | |||||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-13 | |||||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-31 | |||||
| 2019-09-30 | 0.00% 10-Q · filed 2019-11-14 | |||||
| 2019-06-30 | 0.00% 10-Q · filed 2019-08-13 | |||||
| 2019-03-31 | 0.00% 10-Q · filed 2019-05-20 | |||||
| 2018-09-30 | 0.00% 10-Q · filed 2018-11-14 | |||||
| 2018-06-30 | 0.00% 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |